ZA9510702B - Cross-linked microparticulars and their use as therapeutic vehicles - Google Patents

Cross-linked microparticulars and their use as therapeutic vehicles

Info

Publication number
ZA9510702B
ZA9510702B ZA9510702A ZA9510702A ZA9510702B ZA 9510702 B ZA9510702 B ZA 9510702B ZA 9510702 A ZA9510702 A ZA 9510702A ZA 9510702 A ZA9510702 A ZA 9510702A ZA 9510702 B ZA9510702 B ZA 9510702B
Authority
ZA
South Africa
Prior art keywords
linked
cross
microparticulars
vehicles
microparticles
Prior art date
Application number
ZA9510702A
Other languages
English (en)
Inventor
Andrew Derek Sutton
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of ZA9510702B publication Critical patent/ZA9510702B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9510702A 1994-12-16 1995-12-15 Cross-linked microparticulars and their use as therapeutic vehicles ZA9510702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94309417 1994-12-16

Publications (1)

Publication Number Publication Date
ZA9510702B true ZA9510702B (en) 1996-12-17

Family

ID=8217949

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510702A ZA9510702B (en) 1994-12-16 1995-12-15 Cross-linked microparticulars and their use as therapeutic vehicles

Country Status (19)

Country Link
EP (1) EP0796090B1 (fr)
JP (1) JP4350165B2 (fr)
CN (1) CN1175208A (fr)
AT (1) ATE234080T1 (fr)
AU (1) AU692019B2 (fr)
BR (1) BR9510462A (fr)
CA (1) CA2207077C (fr)
CZ (1) CZ183797A3 (fr)
DE (1) DE69529917T2 (fr)
DK (1) DK0796090T3 (fr)
ES (1) ES2191721T3 (fr)
FI (1) FI972546A (fr)
HU (1) HUT77369A (fr)
NO (1) NO972554D0 (fr)
NZ (1) NZ297072A (fr)
PL (1) PL321018A1 (fr)
PT (1) PT796090E (fr)
WO (1) WO1996018388A2 (fr)
ZA (1) ZA9510702B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
WO1997044015A1 (fr) * 1996-05-17 1997-11-27 Andaris Limited Microparticules et utilisation de ces dernieres pour soigner des plaies
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
GB9615435D0 (en) * 1996-07-23 1996-09-04 Andaris Ltd Spray-dried product and its therapeutic use
EP0949932A1 (fr) * 1996-10-19 1999-10-20 Quadrant Healthcare (UK) Limited Utilisation de microcapsules creuses a des fins diagnostiques et therapeutiques
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
CA2269335C (fr) * 1996-10-21 2010-05-25 Quadrant Healthcare (Uk) Limited Substituts de plaquettes et procedes de conjugaison appropries pour leur preparation
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
WO1998033486A1 (fr) * 1997-01-30 1998-08-06 Quadrant Healthcare (Uk) Limited Procede et appareil pour le traitement de dechets hospitaliers
CA2294494A1 (fr) 1997-06-05 1998-12-10 Richard C. K. Yen Microspheres enrobees de fibrinogene
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9724143D0 (en) 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1458360B1 (fr) 2001-12-19 2011-05-11 Novartis AG Administration pulmonaire d'aminoglycosides
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
KR101142583B1 (ko) * 2004-01-07 2012-05-11 세이가가쿠 고교 가부시키가이샤 히알루론산 유도체 및 그것을 포함하는 약제
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
EP2216054A1 (fr) 2009-02-06 2010-08-11 ProFibrix BV Support extravasculaire biodégradable
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
WO2011083154A1 (fr) 2010-01-08 2011-07-14 Profibrix Bv Adhésif de fibrine en poudre sèche
NO20110653A1 (no) 2011-05-02 2012-11-05 Spiro Medical As Respirasjonsovervakning
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494417B1 (fr) * 1991-01-10 1996-04-17 Basf Corporation Procédé de réticulation de gélatine et incorporation d'un matériau
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents

Also Published As

Publication number Publication date
NO972554L (no) 1997-06-05
CN1175208A (zh) 1998-03-04
MX9704503A (es) 1997-10-31
EP0796090B1 (fr) 2003-03-12
WO1996018388A3 (fr) 1996-08-29
AU4184996A (en) 1996-07-03
AU692019B2 (en) 1998-05-28
NO972554D0 (no) 1997-06-05
CA2207077A1 (fr) 1996-06-20
CZ183797A3 (en) 1997-11-12
JPH10510527A (ja) 1998-10-13
ATE234080T1 (de) 2003-03-15
PT796090E (pt) 2003-07-31
ES2191721T3 (es) 2003-09-16
FI972546A0 (fi) 1997-06-16
DE69529917T2 (de) 2003-12-11
BR9510462A (pt) 1998-12-15
HUT77369A (hu) 1998-03-30
NZ297072A (en) 1999-03-29
DK0796090T3 (da) 2003-06-23
CA2207077C (fr) 2007-02-06
DE69529917D1 (de) 2003-04-17
WO1996018388A2 (fr) 1996-06-20
PL321018A1 (en) 1997-11-24
FI972546A (fi) 1997-07-04
JP4350165B2 (ja) 2009-10-21
EP0796090A2 (fr) 1997-09-24

Similar Documents

Publication Publication Date Title
ZA9510702B (en) Cross-linked microparticulars and their use as therapeutic vehicles
MX9702357A (es) Microparticulas secadas por aspersion como vehiculos terapeuticos.
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
EP0951917A3 (fr) Administration de particules, en particulier des agents thérapeutiques en forme de poudre
MY120109A (en) Disposable body fluid absorbent garment
NO972814D0 (no) Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav
MX9707392A (es) Particulas a base de poliaminoacido(s) para utilizarse como vectores de principio(s) activo(s), y metodos para su preparacion.
DE69522338D1 (de) Behandlung von untereinander vernetzten partikelaggregaten mit latex zur erhöhung der flexibilität von porösen absorbierenden makrostrukturen
ATE5235T1 (de) Flocken aus ionenaustauschharzen, ihre herstellung und ihre wiederbelebung und diese flocken verwendendes ionenaustausch- und filtrationsverfahren.
EP1329211A4 (fr) Resine antibacterienne
AU1754997A (en) Absorbent gelling materials of cross-linked polyaspartate
MY116291A (en) Method of production of particular polymers
MY110150A (en) Highly absorbent polymer
IL122972A0 (en) Photochemically cross-linked polysaccharide derivatives their preparation and use
ATE286081T1 (de) Verfahren zur herstellung von polymerteilchen
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
Paul et al. Modified hydroxyapatite microspheres as immunoadsorbent for plasma perfusion: preliminary study
MY110727A (en) Hydrated granular carrier prepared from polyvinyl alcohol and activated charcoal for biological treatment apparatus
Salzman The current status of fluoxetine.
RU99106170A (ru) Способ профилактики и лечения гиперэндотоксинемии
SHINOHARA Dress Situations after the Meiji Restoration
Suzuki et al. The effect of choreito on ureteral stone
RU95105648A (ru) Средство для лечения ран
HELLER Research on the size and shape of large molecules and colloidal particles(Size and shape of large molecules and colloidal particle research)[Final Report, 1 Jun. 1970- 30 Nov. 1971]
SU1369055A1 (ru) Биоспецифические адсорбенты липопротеидов и холестерина